Erlocip 150 Mg Tablets

About Erlocip 150 Mg Tablets

Erlocip 150 mg tablets contain erlotinib, a medication used primarily to treat certain types of cancer, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. Erlotinib is a tyrosine kinase inhibitor that works by blocking the action of a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting EGFR, erlotinib can help slow the growth of tumors or shrink existing tumors.

Common uses of Erlocip (erlotinib):

1. Non-small cell lung cancer (NSCLC): It is often used in patients with advanced or metastatic NSCLC whose tumors have mutations in the EGFR gene (EGFR-positive).
2. Pancreatic cancer: It may be used in combination with other chemotherapy drugs to treat advanced pancreatic cancer.
3. Other cancers: In some cases, erlotinib may be used for other types of cancer, depending on the specific circumstances.

How it works:

Erlotinib targets and blocks EGFR, which is overexpressed in many cancer cells. By inhibiting this receptor, the drug prevents the signal that stimulates the cancer cells to divide and grow.

Common side effects of Erlocip:

• Skin rash: A common side effect, often resembling acne, which may appear on the face, chest, or back.
• Diarrhea: This can be a common and sometimes troublesome side effect.
• Fatigue or weakness
• Loss of appetite or weight loss
• Nausea or vomiting
• Mouth sores (stomatitis)
• Liver function abnormalities: It can affect liver function, so regular blood tests are often required.

Important considerations:

• Skin care: Since skin reactions are common, it's important to follow your doctor's advice on how to manage skin symptoms and prevent infections.
• Liver function: Liver function tests are necessary to monitor for potential liver toxicity while on erlotinib.
• Food interactions: Erlotinib should be taken on an empty stomach (at least 1 hour before or 2 hours after food) to ensure proper absorption.
• Drug interactions: Erlotinib can interact with certain medications, such as antacids or drugs that affect liver enzymes, so make sure your doctor is aware of all the medications you're taking.

Since erlotinib is a potent drug used to treat serious conditions, it's essential to follow your healthcare providers instructions carefully and attend regular follow-up appointments.

Targeted Cancer Therapy Solution

Erlocip 150 Mg Tablets utilize advanced pharmaceutical technology to provide patients with an effective oral treatment for NSCLC and pancreatic cancer. By specifically inhibiting the EGFR pathway, Erlocip targets cancer cells while sparing most healthy tissues, helping to minimize unwanted effects.


Reliable Dosage and User Convenience

These pharmaceutical-grade tablets are provided in a sealed, portable blister pack for hygiene and convenience. The oral administration route means no complicated equipment or hospital settings are required, allowing for routine home-based treatment under medical supervision.


Safe, Controlled, and Prescribed Use

Erlocip is available solely on prescription, ensuring its use is carefully monitored by healthcare professionals. The medication remains effective and stable when stored below 30C in a cool, dry environment, safeguarding its quality throughout its 24-month shelf life.